These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 30691475)
41. High lung-metastatic variant of human osteosarcoma cells, selected by passage of lung metastasis in nude mice, is associated with increased expression of α(v)β(3) integrin. Tome Y; Kimura H; Maehara H; Sugimoto N; Bouvet M; Tsuchiya H; Kanaya F; Hoffman RM Anticancer Res; 2013 Sep; 33(9):3623-7. PubMed ID: 24023288 [TBL] [Abstract][Full Text] [Related]
42. Survival and prognostic factors at time of diagnosis in high-grade appendicular osteosarcoma: a 21 year single institution evaluation from east Denmark. Colding-Rasmussen T; Thorn AP; Horstmann P; Rechnitzer C; Hjalgrim LL; Krarup-Hansen A; Petersen MM Acta Oncol; 2018 Mar; 57(3):420-425. PubMed ID: 28741397 [TBL] [Abstract][Full Text] [Related]
43. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma. Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480 [TBL] [Abstract][Full Text] [Related]
44. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Kaya M; Wada T; Akatsuka T; Kawaguchi S; Nagoya S; Shindoh M; Higashino F; Mezawa F; Okada F; Ishii S Clin Cancer Res; 2000 Feb; 6(2):572-7. PubMed ID: 10690541 [TBL] [Abstract][Full Text] [Related]
45. Targeting αvβ3 and αvβ5 integrins inhibits pulmonary metastasis in an intratibial xenograft osteosarcoma mouse model. Gvozdenovic A; Boro A; Meier D; Bode-Lesniewska B; Born W; Muff R; Fuchs B Oncotarget; 2016 Aug; 7(34):55141-55154. PubMed ID: 27409827 [TBL] [Abstract][Full Text] [Related]
46. Actin-like protein 6A is a novel prognostic indicator promoting invasion and metastasis in osteosarcoma. Sun W; Wang W; Lei J; Li H; Wu Y Oncol Rep; 2017 Apr; 37(4):2405-2417. PubMed ID: 28260090 [TBL] [Abstract][Full Text] [Related]
47. MicroRNA-1908 is a biomarker for poor prognosis in human osteosarcoma. Lian D; Wang ZZ; Liu NS Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1258-62. PubMed ID: 27097944 [TBL] [Abstract][Full Text] [Related]
48. Monocarboxylate Transporter 4 (MCT4) Overexpression Is Correlated with Poor Prognosis of Osteosarcoma. Liu Y; Sun X; Huo C; Sun C; Zhu J Med Sci Monit; 2019 Jun; 25():4278-4284. PubMed ID: 31177263 [TBL] [Abstract][Full Text] [Related]
49. Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma. Li F; Cao L; Hang D; Wang F; Wang Q Int J Clin Exp Pathol; 2015; 8(9):11414-20. PubMed ID: 26617868 [TBL] [Abstract][Full Text] [Related]
50. High expression levels of Cyr61 and VEGF are associated with poor prognosis in osteosarcoma. Liu Y; Zhang F; Zhang Z; Wang D; Cui B; Zeng F; Huang L; Zhang Q; Sun Q Pathol Res Pract; 2017 Aug; 213(8):895-899. PubMed ID: 28647210 [TBL] [Abstract][Full Text] [Related]
51. The clinical significance of changes in ezrin expression in osteosarcoma of children and young adults. Lugowska I; Mierzejewska E; Lenarcik M; Klepacka T; Koch I; Michalak E; Szamotulska K Tumour Biol; 2016 Sep; 37(9):12071-12078. PubMed ID: 27207343 [TBL] [Abstract][Full Text] [Related]
52. The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences. Tsuda Y; Ogura K; Shinoda Y; Kobayashi H; Tanaka S; Kawai A BMC Cancer; 2018 May; 18(1):614. PubMed ID: 29855362 [TBL] [Abstract][Full Text] [Related]
53. Clinical significance of hypoxia-inducible factor 1 and VEGF-A in osteosarcoma. Zhao H; Wu Y; Chen Y; Liu H Int J Clin Oncol; 2015 Dec; 20(6):1233-43. PubMed ID: 26077139 [TBL] [Abstract][Full Text] [Related]
54. Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients. Nataraj V; Rastogi S; Khan SA; Sharma MC; Agarwala S; Vishnubhatla S; Bakhshi S Clin Transl Oncol; 2016 Sep; 18(9):937-44. PubMed ID: 26742936 [TBL] [Abstract][Full Text] [Related]
55. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma. Tian ZZ; Guo XJ; Zhao YM; Fang Y Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857 [TBL] [Abstract][Full Text] [Related]
56. Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma. Wang NG; Wang DC; Tan BY; Wang F; Yuan ZN Int J Clin Exp Pathol; 2015; 8(8):9314-9. PubMed ID: 26464682 [TBL] [Abstract][Full Text] [Related]
57. Prognostic implication of immunohistochemical Runx2 expression in osteosarcoma. Won KY; Park HR; Park YK Tumori; 2009; 95(3):311-6. PubMed ID: 19688969 [TBL] [Abstract][Full Text] [Related]
58. The expression of Eps15 homology domain 1 is negatively correlated with disease-free survival and overall survival of osteosarcoma patients. Yu H; Qu G; Wang Y; Mai W; Bao JJ; Song C; Yao M J Orthop Surg Res; 2019 Apr; 14(1):103. PubMed ID: 30975166 [TBL] [Abstract][Full Text] [Related]
59. Role of integrin-linked kinase in osteosarcoma progression. Rhee SH; Han I; Lee MR; Cho HS; Oh JH; Kim HS J Orthop Res; 2013 Oct; 31(10):1668-75. PubMed ID: 23784942 [TBL] [Abstract][Full Text] [Related]
60. Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma. Ren Z; Liang S; Yang J; Han X; Shan L; Wang B; Mu T; Zhang Y; Yang X; Xiong S; Wang G Tumour Biol; 2016 Apr; 37(4):5089-96. PubMed ID: 26546437 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]